As of 2026-03-31, 中成药（部分国产品牌）'s data on the DeepSeek platform in the 医药行业 category shows: The overall mention rate is 0.00%, below the industry average by 6.1 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 5 competitors in the same category, 中成药（部分国产品牌）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
中成药（部分国产品牌）'s Mention Rate is 0.00%, lower than 0.6% of competitors
中成药（部分国产品牌）'s First Mention is 0.00%, lower than 0.9% of competitors
中成药（部分国产品牌）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
中成药（部分国产品牌）'s Positive Rate is 0.00%, lower than 8.9% of competitors
中成药（部分国产品牌）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 拜拜耳 | 10.2% | 2.04% | 0% | 6.12% | 0% | View Details |
| 华华润三九 | 8.16% | 2.04% | 0% | 8.16% | 0% | View Details |
| 葵葵花药业 | 8.16% | 0% | 0% | 0% | 8.16% | View Details |
| 北北京同仁堂 | 2.04% | 0% | 0% | 2.04% | 0% | View Details |
| 德德开医药 | 2.04% | 0% | 0% | 2.04% | 0% | View Details |
| 中中成药（部分国产品牌） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
